Announced
Completed
Financials
Tags
drug manufacturing
pharmaceutical contract development
Pharmaceuticals
Netherlands
Public
Acquisition
Completed
Friendly
Single Bidder
Synopsis
Thermo Fisher Scientific Inc., the world leader in serving science, and Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per share in cash. The transaction represents a purchase price of approximately $7.2bn, which includes the assumption of approximately $2bn of net debt.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.